New or improved vaccines anticipated by 2015:

• Rotavirus °

• Human papilloma virus °

• Pneumococcus (improved conjugate or protein-based) °

• Japanese B encephalitis (improved) °

• Meningococcus A (multi-serotype conjugate)°

• Measles (aerosol)°

• Polio (inactivated vaccines based on Sabin strains)°

• Polio (monovalent OPV type 1)°°

• Dengue°°

• Group A Streptococcus°°

• RSV°°

• Shigella°°

• ETEC°°

• Typhoid (conjugate)°°

• West Nile Fever°°

• SARS°°

• Malaria°°

• DTaP (with two P antigens)°°

• New combinations of existing vaccines°°

• Influenza for pandemic response

° Late stage of development

°°Licensing expected in 2010-2015